MDGL announcements Madrigal Pharmaceuticals, Inc. announcements and dividends declared NASDAQ
Madrigal Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Madrigal Pharmaceuticals, Inc. MDGL
Madrigal Pharmaceuticals, Inc. MDGL listed on NASDAQ and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Madrigal Pharmaceuticals, Inc. MDGL
Madrigal Pharmaceuticals Posts Wider Loss In Q1
(RTTNews) - Wednesday, Madrigal Pharmaceuticals, Inc. (MDGL) announced its first-quarter financial results, reporting a net loss of .4 million, or .25 a share, compared to .2 million, or .61 a share, in the previous year.
Announcement as on 06 May 2026
Wall Street Thinks Madrigal Pharmaceuticals Could Climb 93%. Here's Why It Could Happen Soon.
Madrigal Pharmaceuticals (NASDAQ: MDGL) may not be a familiar name to many investors, but the consensus of Wall Street analysts expects its shares to rise by 93% within the next 12 months. That's assuming its lead candidate, resmetirom, is approved for sal
Announcement as on 27 September 2023
HC Wainwright & Co. Reiterates Madrigal Pharmaceuticals (MDGL) Buy Recommendation
Fintel reports that on September 14, 2023, HC Wainwright & Co. reiterated coverage of Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy recommendation.
Announcement as on 14 September 2023
: Madrigal Pharmaceuticals shares fall after new CEO named
Shares of Madrigal Pharmaceuticals Inc. MDGL fell more than 7% premarket on Monday after the company appointed Bill Sibold, a former Sanofi SNY executive, as its new CEO. Sibold succeeds Dr. Paul Friedman, the company’s CEO since 2016, who will continue
Announcement as on 11 September 2023
: Madrigal Pharmaceuticals’ stock up 5% as company starts rolling submission for FDA approval of NASH treatment
Madrigal Pharmaceuticals Inc.’s stock MDGL rose 5% Friday after the company said it has started a rolling submission of a New Drug Application to the U.S. Food and Drug Administration seeking accelerated approval of its resmetirom as a treatment for, non
Announcement as on 30 June 2023
Announcements by Madrigal Pharmaceuticals, Inc. first page | Next page |
MDGL Madrigal Pharmaceuticals, Inc. current price & indicator signals
Recent prices of MDGL Madrigal Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 26 Tue May 2026 | 524.28 | 508.01 to 529.00 | 1.36% | 1.18 times |
| 22 Fri May 2026 | 517.26 | 507.06 to 520.89 | 0.71% | 0.57 times |
| 21 Thu May 2026 | 513.59 | 503.26 to 519.99 | 0.02% | 0.75 times |
| 20 Wed May 2026 | 513.47 | 499.34 to 523.16 | 0.32% | 1.29 times |
| 19 Tue May 2026 | 511.82 | 508.86 to 528.99 | -1.99% | 0.92 times |
| 18 Mon May 2026 | 522.23 | 501.02 to 523.85 | -0.28% | 1.16 times |
| 15 Fri May 2026 | 523.69 | 522.40 to 543.78 | -3% | 0.79 times |
| 14 Thu May 2026 | 539.89 | 518.32 to 547.24 | 4.05% | 1.23 times |
| 13 Wed May 2026 | 518.87 | 506.03 to 523.57 | 1.69% | 1.34 times |
| 12 Tue May 2026 | 510.26 | 490.13 to 511.11 | 2.66% | 0.84 times |
| 11 Mon May 2026 | 497.03 | 493.57 to 513.36 | -2.55% | 1.1 times |
| 08 Fri May 2026 | 510.04 | 510.00 to 541.57 | -4.64% | 1.35 times |
Videos related to: MDGL announcements Madrigal Pharmaceuticals, Inc. announcements and dividends declared NASDAQ
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


